Innospec Inc. (IOSP)
NASDAQ: IOSP
· Real-Time Price · USD
86.00
-2.33 (-2.64%)
At close: May 21, 2025, 3:59 PM
85.96
-0.05%
After-hours: May 21, 2025, 05:20 PM EDT
Innospec Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fuel Specialties Revenue | 701.1M | 695.9M | 222.2M | 339.8M | 255M | 479.9M | 400.6M | 523.8M | 509.6M | 758.3M | 682.2M | 567.4M | 179.6M |
| Fuel Specialties Revenue Growth | +0.75% | +213.19% | -34.61% | +33.25% | -46.86% | +19.80% | -23.52% | +2.79% | -32.80% | +11.16% | +20.23% | +215.92% | n/a |
| Oilfield Services Revenue | 490.6M | 691.3M | n/a | n/a | n/a | n/a | n/a | 304.4M | 191.7M | 194.5M | 223.5M | 192.4M | n/a |
| Oilfield Services Revenue Growth | -29.03% | n/a | n/a | n/a | n/a | n/a | n/a | +58.79% | -1.44% | -12.98% | +16.16% | n/a | n/a |
| Performance Chemicals Revenue | 653.7M | 561.6M | n/a | n/a | n/a | n/a | n/a | 419.5M | 138.7M | n/a | n/a | n/a | n/a |
| Performance Chemicals Revenue Growth | +16.40% | n/a | n/a | n/a | n/a | n/a | n/a | +202.45% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 69.3M | 81.1M | 66.8M | 73.4M | 92.7M | 101M | 83.7M | 105.6M | 94.5M | 96.6M | 95.8M | 83.4M | 84.9M | 69.7M | 71.2M | 62.7M | 63.6M | 54.9M | 54.2M | 63.5M | 64.4M | 66M | 71.2M | 71.2M | 72.5M | 63.2M | 64.7M | 65.8M | 67.3M | 62.6M | 60.7M | 60.9M | 55.3M | 56.4M | 56.1M | 53.1M | 43.9M | 55.1M | 52.7M | 50.2M | 48.7M |
| Selling, General, and Administrative Revenue Growth | -14.55% | +21.41% | -8.99% | -20.82% | -8.22% | +20.67% | -20.74% | +11.75% | -2.17% | +0.84% | +14.87% | -1.77% | +21.81% | -2.11% | +13.56% | -1.42% | +15.85% | +1.29% | -14.65% | -1.40% | -2.42% | -7.30% | 0.00% | -1.79% | +14.72% | -2.32% | -1.67% | -2.23% | +7.51% | +3.13% | -0.33% | +10.13% | -1.95% | +0.53% | +5.65% | +20.96% | -20.33% | +4.55% | +4.98% | +3.08% | n/a |
| Research and Development Revenue | 12.7M | 12.7M | 11.1M | 12.2M | 11.8M | 8.9M | 11.6M | 10.6M | 10.6M | 8.4M | 10.1M | 10.1M | 10.1M | 9.5M | 10.3M | 8.6M | 9M | 6.5M | 7.7M | 8.1M | 8.6M | 8.4M | 9.7M | 8.2M | 9.1M | 8.3M | 8.1M | 8.7M | 8.3M | 7.6M | 7.9M | 8.5M | 7.4M | 5.8M | 6.5M | 6.2M | 6.9M | 6M | 6.6M | 6.5M | 6.2M |
| Research and Development Revenue Growth | 0.00% | +14.41% | -9.02% | +3.39% | +32.58% | -23.28% | +9.43% | 0.00% | +26.19% | -16.83% | 0.00% | 0.00% | +6.32% | -7.77% | +19.77% | -4.44% | +38.46% | -15.58% | -4.94% | -5.81% | +2.38% | -13.40% | +18.29% | -9.89% | +9.64% | +2.47% | -6.90% | +4.82% | +9.21% | -3.80% | -7.06% | +14.86% | +27.59% | -10.77% | +4.84% | -10.14% | +15.00% | -9.09% | +1.54% | +4.84% | n/a |